Biocartis Group NV (BCART.BR) Stock Fundamental Analysis
Europe • Euronext Brussels • EBR:BCART • BE0974281132
0.29 EUR
+0.01 (+1.75%)
Last: Sep 22, 2023, 07:00 PM
We assign a fundamental rating of 2 out of 10 to BCART. BCART was compared to 68 industry peers in the Health Care Equipment & Supplies industry. BCART may be in some trouble as it scores bad on both profitability and health. BCART is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year BCART has reported negative net income.
- BCART had a negative operating cash flow in the past year.
1.2 Ratios
- BCART has negative profitability rations, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Gross Margin, with a value of 48.16%, BCART is in line with its industry, outperforming 42.59% of the companies in the same industry.
- BCART's Gross Margin has declined in the last couple of years.
- BCART does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 48.16% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y-3.85%
2. Health
2.1 Basic Checks
- BCART does not have a ROIC to compare to the WACC, probably because it is not profitable.
- BCART has more shares outstanding than it did 1 year ago.
- BCART has a better debt/assets ratio than last year.
2.2 Solvency
- BCART has an Altman-Z score of -5.89. This is a bad value and indicates that BCART is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of BCART (-5.89) is worse than 94.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.89 |
ROIC/WACCN/A
WACC5.17%
2.3 Liquidity
- A Current Ratio of 1.65 indicates that BCART should not have too much problems paying its short term obligations.
- BCART has a Current ratio (1.65) which is in line with its industry peers.
- BCART has a Quick Ratio of 1.20. This is a normal value and indicates that BCART is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.20, BCART is in line with its industry, outperforming 48.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.65 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
- The earnings per share for BCART have decreased by -1.55% in the last year.
- Looking at the last year, BCART shows a quite strong growth in Revenue. The Revenue has grown by 19.08% in the last year.
- The Revenue has been growing by 22.36% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-1.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.11%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y15.36%
Revenue growth 5Y22.36%
Sales Q2Q%17.8%
3.2 Future
- The Earnings Per Share is expected to grow by 24.29% on average over the next years. This is a very strong growth
- Based on estimates for the next years, BCART will show a very strong growth in Revenue. The Revenue will grow by 21.39% on average per year.
EPS Next Y36%
EPS Next 2Y31.91%
EPS Next 3Y24.29%
EPS Next 5YN/A
Revenue Next Year3.76%
Revenue Next 2Y16.6%
Revenue Next 3Y21.39%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for BCART. In the last year negative earnings were reported.
- Also next year BCART is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as BCART's earnings are expected to grow with 24.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.91%
EPS Next 3Y24.29%
5. Dividend
5.1 Amount
- No dividends for BCART!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Biocartis Group NV / BCART.BR FAQ
What is the ChartMill fundamental rating of Biocartis Group NV (BCART.BR) stock?
ChartMill assigns a fundamental rating of 2 / 10 to BCART.BR.
Can you provide the valuation status for Biocartis Group NV?
ChartMill assigns a valuation rating of 1 / 10 to Biocartis Group NV (BCART.BR). This can be considered as Overvalued.
How profitable is Biocartis Group NV (BCART.BR) stock?
Biocartis Group NV (BCART.BR) has a profitability rating of 0 / 10.
How financially healthy is Biocartis Group NV?
The financial health rating of Biocartis Group NV (BCART.BR) is 2 / 10.